PEOPLE - Apax Partners (France) makes appointments:
This article was originally published in Clinica
Capital investment company Apax Partners (Paris, France) has announced five key appointments. Bruno Candelier has been appointed to the leveraged buy out team. Mr Candelier is to be joined by Guillaume-Olivier Dore, who will be responsible for business development. Olivier Morali and Alexandre Scherer will join the biotechnology and health team, whilst Thomas de Villeneuve has been appointed to the media relations group.
You may also be interested in...
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.
Metabesity is a complex issue that will require a multi-disciplinary approach, concerted effort and clear regulatory pathway to achieve solutions.